Related Experiment Video
Updated: Jun 8, 2025
Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
Published on: June 13, 2011
Omega-3 Fatty Acids and Neuroinflammation in Depression: Targeting Damage-Associated Molecular Patterns and Neural
Ikbal Andrian Malau1,2, Jane Pei-Chen Chang1,2,3, Yi-Wen Lin4
1Mind-Body Interface Research Center (MBI-Lab), China Medical University Hospital, Taichung 404, Taiwan.
Abstract:
Major Depressive Disorder (MDD) is a prevalent mental health condition with a complex pathophysiology involving neuroinflammation, neurodegeneration, and disruptions in neuronal and glial cell function. Microglia, the innate immune cells of the central nervous system, release inflammatory cytokines in response to pathological changes associated with MDD. Damage-associated molecular patterns (DAMPs) act as alarms, triggering microglial activation and subsequent inflammatory cytokine release. This review examines the cellular mechanisms underlying MDD pathophysiology, focusing on the lipid-mediated modulation of neuroinflammation. We explore the intricate roles of microglia and astrocytes in propagating inflammatory cascades and discuss how these processes affect neuronal integrity at the cellular level. Central to our analysis are three key molecules: High Mobility Group Box 1 (HMGB1) and S100 Calcium Binding Protein β (S100β) as alarmins, and Neuron-Specific Enolase (NSE) as an indicator of neuronal stress. We present evidence from in vitro and ex vivo studies demonstrating how these molecules reflect and contribute to the neuroinflammatory milieu characteristic of MDD. The review then explores the potential of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) as neuroinflammation modulators, examining their effects on microglial activation, cytokine production, and neuronal resilience in cellular models of depression. We critically analyze experimental data on how ω-3 PUFA supplementation influences the expression and release of HMGB1, S100β, and NSE in neuronal and glial cultures. By integrating findings from lipidomic and cellular neurobiology, this review aims to elucidate the mechanisms by which ω-3 PUFAs may exert their antidepressant effects through modulation of neuroinflammatory markers. These insights contribute to our understanding of lipid-mediated neuroprotection in MDD and may inform the development of targeted, lipid-based therapies for both depression and neurodegenerative disorders.
Insights
Major Depressive Disorder involves neuroinflammation. Omega-3 fatty acids may reduce this inflammation by modulating key molecules like HMGB1, S100β, and NSE, offering potential antidepressant effects.
Area of Science:
- Neuroscience
- Cellular Biology
- Immunology
Background:
- Major Depressive Disorder (MDD) pathophysiology involves neuroinflammation, neurodegeneration, and glial cell dysfunction.
- Microglia activation by damage-associated molecular patterns (DAMPs) releases inflammatory cytokines, contributing to MDD.
- Key molecules like High Mobility Group Box 1 (HMGB1), S100 Calcium Binding Protein β (S100β), and Neuron-Specific Enolase (NSE) are implicated in MDD neuroinflammation.
Purpose of the Study:
- To review cellular mechanisms of MDD pathophysiology, focusing on lipid-mediated neuroinflammation.
- To examine the roles of microglia and astrocytes in MDD inflammatory cascades.
- To explore the potential of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in modulating MDD neuroinflammation.
Main Methods:
- Analysis of in vitro and ex vivo studies on MDD cellular mechanisms.
- Investigation of HMGB1, S100β, and NSE as indicators of neuronal stress and inflammation.
- Evaluation of ω-3 PUFA effects on microglial activation, cytokine production, and neuronal resilience in cellular models.
Main Results:
- HMGB1 and S100β act as alarmins, while NSE indicates neuronal stress in MDD.
- ω-3 PUFAs demonstrate potential in modulating microglial activation and cytokine release.
- Experimental data show ω-3 PUFA supplementation influences HMGB1, S100β, and NSE levels in neuronal and glial cultures.
Conclusions:
- MDD involves complex neuroinflammatory processes modulated by lipids.
- ω-3 PUFAs may exert antidepressant effects by reducing neuroinflammation and promoting neuroprotection.
- Targeted, lipid-based therapies hold promise for treating MDD and neurodegenerative disorders.
